Effects of COVID-19 on lung function and gas exchange

• Conditions: J84; J18; U07.1; Other interstitial pulmonary diseases; Pneumonia, organism unspecified; COVID-19, virus identified

• Registration Number: DRKS00022082
• Lead Sponsor: Klinik und Poliklinik für Anästhesiologie und Operative Intensivmedizin; Universitätsklinikum Bonn

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-06-15
• Study Completion: 2022-05-03
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 74

Inclusion Criteria

PCR detection of SARS-CoV-19

Exclusion Criteria

acute infection,
history of coronary heart disease (CHD);
patients with lung fibrosis or impaired pulmonary diffusion capacity

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Comparison of TLCO after recovery from COVID-19 after 12 weeks.

Secondary Outcome Measures

Name	Time	Method
- longitudinal changes of pulmonary function and physical endurance after recovery of COVID-19<br>- predictive role of FEV1/VC to estimate TLCO<br>- markers to predict patients with mild or severe progress <br>